Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03056872 · ClinicalTrials.gov registry record

Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes

A clinical trial, sponsored by University of Minnesota.

Completed
Registry status
60
Enrollment target

NCT03056872 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 60 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03056872 has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

Alcohol dependence is among the most common and costly public health problems affecting the nation. Among individuals with alcohol use disorder (AUD), those with (vs. without) a co-occurring anxiety disorder (AnxD) are as much as twice as likely to relapse in the months following AUD treatment. Dysregulation of biological stress-mood systems predict and correlate with AUD relapse and AnxD symptomatology. In contrast, stress system re-regulation correlates with improved AUD treatment outcomes but has not been examined with respect to AUD recovery and relapse in co-occurring AUD+AnxD.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-10-05
Est. Completion 2023-05-12

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT03056872

The ClinicalTrials.gov registry entry for NCT03056872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03056872 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03056872 about?

NCT03056872 is a clinical study titled "Stress Reactivity as a Determinant in Co-occurring Alcohol Use and Anxiety Disorder: Diagnosis and Alcohol Use Outcomes". Alcohol dependence is among the most common and costly public health problems affecting the nation. Among individuals with alcohol use disorder (AUD), those with (vs. without) a co-occurring anxiety disorder (AnxD) are as much as twice as likely to relapse in the months following AUD treatment. Dysr...

What is the current status of trial NCT03056872?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-10-05. Estimated completion is 2023-05-12.

Who is sponsoring clinical trial NCT03056872?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.